Urmi Bajpai

520 total citations
28 papers, 237 citations indexed

About

Urmi Bajpai is a scholar working on Molecular Biology, Ecology and Infectious Diseases. According to data from OpenAlex, Urmi Bajpai has authored 28 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Ecology and 10 papers in Infectious Diseases. Recurrent topics in Urmi Bajpai's work include Bacteriophages and microbial interactions (12 papers), Tuberculosis Research and Epidemiology (9 papers) and Biochemical and Molecular Research (7 papers). Urmi Bajpai is often cited by papers focused on Bacteriophages and microbial interactions (12 papers), Tuberculosis Research and Epidemiology (9 papers) and Biochemical and Molecular Research (7 papers). Urmi Bajpai collaborates with scholars based in India, China and United States. Urmi Bajpai's co-authors include Jyoti Rani, Srinivasan Ramachandran, Durga Prasanna Misra, Samudrala Gourinath, Ramachandran Vijayan, Ritam Das, Yumnam Silla, Shilpi Singh, Andrew M. Lynn and Geetha Vani Rayasam and has published in prestigious journals such as Scientific Reports, Applied Microbiology and Biotechnology and Molecules.

In The Last Decade

Urmi Bajpai

27 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urmi Bajpai India 11 127 77 68 41 29 28 237
Stephanie M. Reeve United States 11 141 1.1× 74 1.0× 28 0.4× 31 0.8× 31 1.1× 18 290
O. Kiryukhina United States 9 201 1.6× 96 1.2× 38 0.6× 22 0.5× 52 1.8× 15 336
Yoshimasa Ishizaki Japan 9 179 1.4× 120 1.6× 29 0.4× 64 1.6× 17 0.6× 14 338
Steven M. Crespo‐Carbone United States 9 132 1.0× 41 0.5× 31 0.5× 34 0.8× 16 0.6× 9 244
Sudha Ravishankar India 10 187 1.5× 91 1.2× 42 0.6× 61 1.5× 14 0.5× 13 292
Leonardo Mariño Italy 10 164 1.3× 119 1.5× 39 0.6× 65 1.6× 20 0.7× 21 320
Samantha Wellington United States 7 245 1.9× 138 1.8× 20 0.3× 80 2.0× 19 0.7× 8 358
Muhammad Shahab China 11 207 1.6× 53 0.7× 17 0.3× 55 1.3× 50 1.7× 45 306
Kirsten J. Meyer United States 9 143 1.1× 22 0.3× 19 0.3× 31 0.8× 20 0.7× 15 271
Suereta Fortuin South Africa 9 191 1.5× 123 1.6× 44 0.6× 84 2.0× 6 0.2× 14 307

Countries citing papers authored by Urmi Bajpai

Since Specialization
Citations

This map shows the geographic impact of Urmi Bajpai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urmi Bajpai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urmi Bajpai more than expected).

Fields of papers citing papers by Urmi Bajpai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urmi Bajpai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urmi Bajpai. The network helps show where Urmi Bajpai may publish in the future.

Co-authorship network of co-authors of Urmi Bajpai

This figure shows the co-authorship network connecting the top 25 collaborators of Urmi Bajpai. A scholar is included among the top collaborators of Urmi Bajpai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urmi Bajpai. Urmi Bajpai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verma, Sonia, Hasham S. Sofi, Rahul Sharma, et al.. (2025). Dry powder Inhalation of lytic mycobacteriophages for adjunct therapy in a mouse model of infection with Mycobacterium tuberculosis. Tuberculosis. 152. 102631–102631. 2 indexed citations
2.
Jain, Vikas, et al.. (2024). Mycobacteriophages: therapeutic approach for mycobacterial infections. Drug Discovery Today. 29(7). 104049–104049. 2 indexed citations
3.
Das, Ritam, et al.. (2024). Insights into the genomic features and lifestyle of B1 subcluster mycobacteriophages. Journal of Basic Microbiology. 64(6). e2400027–e2400027.
5.
Bajpai, Urmi, et al.. (2024). Discovery and characterization of a novel LysinB from F2 sub-cluster mycobacteriophage RitSun. Scientific Reports. 14(1). 18073–18073. 2 indexed citations
6.
Shah, Sanket, et al.. (2023). Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens. Frontiers in Microbiology. 14. 1170418–1170418. 9 indexed citations
7.
Hanif, Sarmad, et al.. (2023). P10 Phage-encoded lysins as promising antibacterials against uropathogenic Escherichia coli. JAC-Antimicrobial Resistance. 5(Supplement_1). 1 indexed citations
8.
Das, Ritam & Urmi Bajpai. (2022). Functional characterization of a DNA-dependent AAA ATPase in a F-cluster mycobacteriophage. Virus Research. 323. 198957–198957. 2 indexed citations
9.
Raina, Diksha, Praveen K. Chinthakindi, Amit Nargotra, et al.. (2021). Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli. Applied Microbiology and Biotechnology. 105(9). 3611–3623. 8 indexed citations
11.
Das, Ritam, et al.. (2021). Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19. Infectious Diseases and Therapy. 11(1). 53–78. 9 indexed citations
12.
Manohar, Prasanth, et al.. (2020). Characterization and genome analysis of B1 sub-cluster mycobacteriophage PDRPxv. Virus Research. 279. 197884–197884. 19 indexed citations
13.
Bajpai, Urmi, et al.. (2020). Functional characterization of the endolysins derived from mycobacteriophage PDRPxv. World Journal of Microbiology and Biotechnology. 36(6). 83–83. 6 indexed citations
14.
Rani, Jyoti, et al.. (2019). Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Mycobacterium tuberculosis. SLAS DISCOVERY. 25(1). 70–78. 15 indexed citations
15.
Vijayan, Ramachandran, et al.. (2017). Crystal structure of UDP- N -acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1866(3). 397–406. 28 indexed citations
16.
Kumar, Anuradha, et al.. (2016). Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis. Scientific Reports. 6(1). 35134–35134. 22 indexed citations
17.
Bajpai, Urmi, et al.. (2015). Cloning, expression, purification and bioinformatic analysis of 2–methylcitrate synthase from Mycobacterium tuberculosis. Asian Pacific Journal of Tropical Medicine. 8(1). 19–23. 1 indexed citations
18.
Sinha, Swati, et al.. (2015). Functional analysis of TPM domain containing Rv2345 of Mycobacterium tuberculosis identifies its phosphatase activity. Protein Expression and Purification. 111. 23–27. 2 indexed citations
19.
Singh, Shilpi, Urmi Bajpai, & Andrew M. Lynn. (2014). Structure based virtual screening to identify inhibitors against MurE Enzyme of Mycobacterium tuberculosis using AutoDock Vina. Bioinformation. 10(11). 697–702. 14 indexed citations
20.
Lal, Richa, Veereshwar Bhatnagar, Sandeep Agarwala, et al.. (1997). Fungal infections as a xause of morbidity and morality in posterior urethral valves.. Journal of Indian Association of Pediatric Surgeons. 2(4). 130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026